Atypical Antipsychotics as Enhancement Therapy in Rapid Cycling Mood States: A Case Study
Tóm tắt
Rapid cycling is not an uncommon occurrence in patients with bipolar affective disorder. This variant of the disease is notorious for its treatment resistance, in particular, lithium resistance. A full spectrum of cycloid mood states has been described. The author presents five cases in which the addition of atypical antipsychotics resulted in significant symptom relief. An argument for a preferential use of atypical antipsychotics, with their low risk of tardive dyskinesia, is made. General guidelines for the use of atypical antipsychotics in rapid cycling patients are discussed. Atypical antipsychotic medications in “cycloid disorders,” including rapid cycling bipolar disease, are discussed.
Tài liệu tham khảo
Bauer MS, Calabrese J, Dunner DL, et al.: Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 1994; 151:506-515
Calabrese JR, Woyshville MJ: A medication algorithm for treatment of bipolar rapid cycling? J Clin Psychiatry 1995; 56(Suppl): 11-18
Ananth J, Wohl M, Ranganath V, et al.: Rapid cycling patients: Conceptual and etiological factors. Neuro Psycho Bio 1993; 27:193-198
Calabrese JR, Rapport DJ, Kimmel SE, et al.: Rapid cycling bipolar disorder and its treatment with valproate. Can J Psychiatry 1993; 38:(S)57-61
Weiden P, Aquila R, Standard J: Atypical antipsychotic drugs and long term outcome in schizophrenia. J Clin Psychiatry 1996; 57(Suppl 11):53-60
Bymaster F: In vitro and in vivo biochemistry of olanzepine. J Clin Psychiatry 1997; 15 (monogr ser):10-12
Gelenberg AJ, Hopkins HS: Antipsychotic in bipolar disorder. J Clin Psychiatry 1996; 57(Suppl 9):49-52
Lowe MR, Batchelor DH: Depo neuroleptics in manic depressive psychosis. Int Clin Psychopharmacology 1986; 1(Suppl 1): 53-62
Barbini B, Scherillo P, Benedetti F, et al.: Response to clozepine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacology 1997; 12:109-112
Schotte A, Janssen PF, Gommeren W, et al.: Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology 1996; 124:57-73
Zarate CA, Tohen M, Banob MD, et al.: Is clozepine a mood stabilizer. J Clin Psychiatry 1995; 56:108-112
Glazer WM: Olanzepine and the new generation of antipsychotic agents: Patterns of use. J Clin Psychiatry 1997; 58(Suppl 10):18-21
Wehr TA, Sack DA, Rosenthal NE, et al.: Rapid cycling affective disorder: Contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145:179-184
Kramlinger KG, Post RM: Ultrarapid and ultraradian cycling in bipolar affective illness. Br. J Psychiatry; 1996; 168:314-323
Perris C: Morbidity suppressive effect of lithium carbonate in cycloid psychoses. Arch Gen Psychiatry 1978; 35:328-331
Novac A: Lithium carbonate and the cycloid spectrum. J Clin Psychiatry 1985; 46:504-505
Goldberg JF, Harrow M: Kingling in bipolar disorders: A longitudinal followup study. Bio Psychiatry 1994; 35:70-72
Bell IR, Rossi J III, Gilbert ME, et al.: Testing the neurosensitization and kingling hypothesis for illness from low levels of environmental chemicals. Environ Health Perspect 1997; 105(Suppl):539-547
McNamara JO: Analysis of the molecular basis of kingling development. Psychiatry Clin Neurosci 1995; 49:175-178
Post RM, Weiss RD, Smith M, et al.: Stress, conditioning, and the temporal aspects of affective disorder. Ann NY Acad Sci 1995; 771:677-696
Segal ZV, Williams JM, Teasdale JD, et al.: A cognitive science perspective on kingling and episode sensitization and recurrent affective disorder. Psychol Med 1996; 26:371-380
Maj M, Majliano L, Pirozzi R, et al.: Validity of rapid cycling as a course specific for bipolar disorder. Am J Psychiatry 1994; 151:1015-1019
Tollefson GD, Sanger TM: Negative symptoms: A path analytic approach to a double-blind, placebo, and haloperidol-controlled clinical trial with olanzepine. Am J Psychiatry 1997; 154:466-474
Casey DE: How antipsychotic drug pharmacology relates to side effects. J Clin Psychiatry (monogr ser) 1997; 15:30-33
Sanger TM, Tohen M, Tollefson GD, et al.: Olanzepine versus placebo in the treatment of acute mania. Presented at the 9th Biennial Winter Workshop on Schizophrenia, Davos, Switzerland, Feb 7–13, 1998